Jazz Fixed Asset Turnover from 2010 to 2025

JAZZ Stock  USD 137.96  1.91  1.40%   
Jazz Pharmaceuticals Fixed Asset Turnover yearly trend continues to be fairly stable with very little volatility. Fixed Asset Turnover will likely drop to 17.03 in 2025. During the period from 2010 to 2025, Jazz Pharmaceuticals Fixed Asset Turnover regression line of annual values had r-squared of  0.27 and arithmetic mean of  30.35. View All Fundamentals
 
Fixed Asset Turnover  
First Reported
2010-12-31
Previous Quarter
17.9252847
Current Value
17.03
Quarterly Volatility
43.55870125
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jazz Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jazz Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 250 M, Other Operating Expenses of 3.5 B or Operating Income of 752.5 M, as well as many indicators such as Price To Sales Ratio of 1.78, Dividend Yield of 0.0 or PTB Ratio of 1.77. Jazz financial statements analysis is a perfect complement when working with Jazz Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Jazz Pharmaceuticals Correlation against competitors.

Latest Jazz Pharmaceuticals' Fixed Asset Turnover Growth Pattern

Below is the plot of the Fixed Asset Turnover of Jazz Pharmaceuticals PLC over the last few years. It is Jazz Pharmaceuticals' Fixed Asset Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jazz Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Fixed Asset Turnover10 Years Trend
Slightly volatile
   Fixed Asset Turnover   
       Timeline  

Jazz Fixed Asset Turnover Regression Statistics

Arithmetic Mean30.35
Geometric Mean18.22
Coefficient Of Variation143.52
Mean Deviation28.19
Median15.48
Standard Deviation43.56
Sample Variance1,897
Range167
R-Value(0.52)
Mean Square Error1,487
R-Squared0.27
Significance0.04
Slope(4.74)
Total Sum of Squares28,460

Jazz Fixed Asset Turnover History

2025 17.03
2024 17.93
2023 16.32
2022 12.14
2021 9.01
2020 9.19
2019 7.98

About Jazz Pharmaceuticals Financial Statements

Jazz Pharmaceuticals investors use historical fundamental indicators, such as Jazz Pharmaceuticals' Fixed Asset Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jazz Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Fixed Asset Turnover 17.93  17.03 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jazz Stock Analysis

When running Jazz Pharmaceuticals' price analysis, check to measure Jazz Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jazz Pharmaceuticals is operating at the current time. Most of Jazz Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jazz Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jazz Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jazz Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.